- Home
- RAPT vs CTS Comparison
RAPT vs CTS Comparison
Compare RAPT & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAPT | CTS |
|---|---|---|
| Founded | 2015 | 1896 |
| Country | United States | United States |
| Employees | 60 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2019 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RAPT | CTS |
|---|---|---|
| Price | $58.00 | $51.87 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $56.22 | N/A |
| AVG Volume (30 Days) | ★ 4.1M | 188.1K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | N/A | ★ 0.30% |
| EPS Growth | N/A | ★ 15.87 |
| EPS | N/A | ★ 2.19 |
| Revenue | N/A | ★ $541,318,000.00 |
| Revenue This Year | N/A | $5.55 |
| Revenue Next Year | N/A | $5.00 |
| P/E Ratio | ★ N/A | $23.91 |
| Revenue Growth | N/A | ★ 4.95 |
| 52 Week Low | $0.71 | $34.02 |
| 52 Week High | $57.99 | $59.66 |
Technical Indicators
Market Signals| Indicator | RAPT | CTS |
|---|---|---|
| Relative Strength Index (RSI) | 78.59 | 46.25 |
| Support Level | $32.00 | $40.41 |
| Resistance Level | N/A | $59.66 |
| Average True Range (ATR) | 0.09 | 1.78 |
| MACD | -0.79 | -0.70 |
| Stochastic Oscillator | 95.31 | 5.56 |
Price Performance
Historical ComparisonAbout RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About CTS CTS Corporation
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.